Rituxan injection specific drug use-results survey
Not Applicable
- Conditions
- Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA)
- Registration Number
- JPRN-UMIN000011549
- Lead Sponsor
- Zenyaku Kogyo Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Safety (infusion-related reactions and infections) 2. Efficacy
- Secondary Outcome Measures
Name Time Method